nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—prostate cancer	0.543	1	CbGaD
Bimatoprost—AKR1C3—Doxorubicin—prostate cancer	0.135	1	CbGbCtD
Bimatoprost—PTGER3—prostate gland—prostate cancer	0.00485	0.131	CbGeAlD
Bimatoprost—PTGFR—prostate gland—prostate cancer	0.00388	0.105	CbGeAlD
Bimatoprost—PTGER1—renal system—prostate cancer	0.00377	0.102	CbGeAlD
Bimatoprost—PTGER3—renal system—prostate cancer	0.00331	0.0894	CbGeAlD
Bimatoprost—AKR1C3—prostate gland—prostate cancer	0.00315	0.0852	CbGeAlD
Bimatoprost—AKR1C3—seminal vesicle—prostate cancer	0.00267	0.0721	CbGeAlD
Bimatoprost—PTGFR—urethra—prostate cancer	0.0026	0.0702	CbGeAlD
Bimatoprost—AKR1C3—Podofilox—Etoposide—prostate cancer	0.00259	1	CbGdCrCtD
Bimatoprost—PTGER3—testis—prostate cancer	0.00214	0.0578	CbGeAlD
Bimatoprost—AKR1C3—urethra—prostate cancer	0.00211	0.0571	CbGeAlD
Bimatoprost—PTGFR—testis—prostate cancer	0.00171	0.0462	CbGeAlD
Bimatoprost—AKR1C3—bone marrow—prostate cancer	0.00162	0.0439	CbGeAlD
Bimatoprost—PTGER3—lymph node—prostate cancer	0.00155	0.0419	CbGeAlD
Bimatoprost—AKR1C3—testis—prostate cancer	0.00139	0.0375	CbGeAlD
Bimatoprost—PTGFR—lymph node—prostate cancer	0.00124	0.0335	CbGeAlD
Bimatoprost—AKR1C3—lymph node—prostate cancer	0.00101	0.0272	CbGeAlD
Bimatoprost—Iloprost—PDE4D—prostate cancer	0.000968	0.245	CrCbGaD
Bimatoprost—Dinoprost Tromethamine—HPGDS—prostate cancer	0.00084	0.213	CrCbGaD
Bimatoprost—Latanoprost—SLC22A1—prostate cancer	0.00073	0.185	CrCbGaD
Bimatoprost—Dinoprostone—HPGDS—prostate cancer	0.000646	0.164	CrCbGaD
Bimatoprost—Tafluprost—PTGS2—prostate cancer	0.000293	0.0743	CrCbGaD
Bimatoprost—Dinoprostone—SLC22A1—prostate cancer	0.00027	0.0684	CrCbGaD
Bimatoprost—Dinoprostone—CYP19A1—prostate cancer	0.000201	0.0509	CrCbGaD
Bimatoprost—Eye disorder—Etoposide—prostate cancer	0.000119	0.000768	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000119	0.000768	CcSEcCtD
Bimatoprost—Bladder pain—Doxorubicin—prostate cancer	0.000119	0.000768	CcSEcCtD
Bimatoprost—Dizziness—Ethinyl Estradiol—prostate cancer	0.000118	0.000764	CcSEcCtD
Bimatoprost—Cough—Mitoxantrone—prostate cancer	0.000116	0.000751	CcSEcCtD
Bimatoprost—Infection—Estradiol—prostate cancer	0.000116	0.000749	CcSEcCtD
Bimatoprost—Angiopathy—Etoposide—prostate cancer	0.000115	0.000746	CcSEcCtD
Bimatoprost—Hypertension—Mitoxantrone—prostate cancer	0.000115	0.000743	CcSEcCtD
Bimatoprost—Mediastinal disorder—Etoposide—prostate cancer	0.000115	0.000741	CcSEcCtD
Bimatoprost—Nervous system disorder—Estradiol—prostate cancer	0.000114	0.000739	CcSEcCtD
Bimatoprost—Eye pain—Epirubicin—prostate cancer	0.000114	0.000738	CcSEcCtD
Bimatoprost—Depression—Capecitabine—prostate cancer	0.000114	0.000735	CcSEcCtD
Bimatoprost—Chest pain—Mitoxantrone—prostate cancer	0.000113	0.000733	CcSEcCtD
Bimatoprost—Skin disorder—Estradiol—prostate cancer	0.000113	0.000732	CcSEcCtD
Bimatoprost—Anxiety—Mitoxantrone—prostate cancer	0.000113	0.00073	CcSEcCtD
Bimatoprost—Rash—Ethinyl Estradiol—prostate cancer	0.000113	0.000728	CcSEcCtD
Bimatoprost—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000113	0.000728	CcSEcCtD
Bimatoprost—Headache—Ethinyl Estradiol—prostate cancer	0.000112	0.000724	CcSEcCtD
Bimatoprost—Infection—Mitoxantrone—prostate cancer	0.000108	0.000698	CcSEcCtD
Bimatoprost—Nausea—Ethinyl Estradiol—prostate cancer	0.000106	0.000686	CcSEcCtD
Bimatoprost—Rhinitis—Docetaxel—prostate cancer	0.000106	0.000685	CcSEcCtD
Bimatoprost—Eye pain—Doxorubicin—prostate cancer	0.000106	0.000683	CcSEcCtD
Bimatoprost—Asthenia—Goserelin—prostate cancer	0.000105	0.000682	CcSEcCtD
Bimatoprost—Skin disorder—Mitoxantrone—prostate cancer	0.000105	0.000682	CcSEcCtD
Bimatoprost—Insomnia—Estradiol—prostate cancer	0.000105	0.000682	CcSEcCtD
Bimatoprost—Pharyngitis—Docetaxel—prostate cancer	0.000105	0.000678	CcSEcCtD
Bimatoprost—Asthenia—Conjugated Estrogens—prostate cancer	0.000104	0.000676	CcSEcCtD
Bimatoprost—Oedema peripheral—Docetaxel—prostate cancer	0.000104	0.000673	CcSEcCtD
Bimatoprost—Pruritus—Goserelin—prostate cancer	0.000104	0.000673	CcSEcCtD
Bimatoprost—Dyspnoea—Estradiol—prostate cancer	0.000104	0.000672	CcSEcCtD
Bimatoprost—Connective tissue disorder—Docetaxel—prostate cancer	0.000104	0.000672	CcSEcCtD
Bimatoprost—Somnolence—Estradiol—prostate cancer	0.000104	0.00067	CcSEcCtD
Bimatoprost—Pruritus—Conjugated Estrogens—prostate cancer	0.000103	0.000666	CcSEcCtD
Bimatoprost—Diplopia—Epirubicin—prostate cancer	0.000103	0.000666	CcSEcCtD
Bimatoprost—Dyspepsia—Estradiol—prostate cancer	0.000103	0.000664	CcSEcCtD
Bimatoprost—Rhinitis—Capecitabine—prostate cancer	0.000103	0.000663	CcSEcCtD
Bimatoprost—Visual impairment—Docetaxel—prostate cancer	0.000102	0.000659	CcSEcCtD
Bimatoprost—Pharyngitis—Capecitabine—prostate cancer	0.000102	0.000657	CcSEcCtD
Bimatoprost—Depression—Prednisone—prostate cancer	0.000101	0.000655	CcSEcCtD
Bimatoprost—Oedema peripheral—Capecitabine—prostate cancer	0.000101	0.000652	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Estradiol—prostate cancer	0.000101	0.000651	CcSEcCtD
Bimatoprost—Connective tissue disorder—Capecitabine—prostate cancer	0.000101	0.00065	CcSEcCtD
Bimatoprost—Pain—Estradiol—prostate cancer	9.97e-05	0.000645	CcSEcCtD
Bimatoprost—Vertigo—Etoposide—prostate cancer	9.94e-05	0.000643	CcSEcCtD
Bimatoprost—Eye disorder—Docetaxel—prostate cancer	9.88e-05	0.000639	CcSEcCtD
Bimatoprost—Visual impairment—Capecitabine—prostate cancer	9.86e-05	0.000638	CcSEcCtD
Bimatoprost—Dizziness—Goserelin—prostate cancer	9.72e-05	0.000629	CcSEcCtD
Bimatoprost—Dyspnoea—Mitoxantrone—prostate cancer	9.68e-05	0.000626	CcSEcCtD
Bimatoprost—Cough—Etoposide—prostate cancer	9.66e-05	0.000625	CcSEcCtD
Bimatoprost—Somnolence—Mitoxantrone—prostate cancer	9.66e-05	0.000624	CcSEcCtD
Bimatoprost—Dizziness—Conjugated Estrogens—prostate cancer	9.63e-05	0.000623	CcSEcCtD
Bimatoprost—Angiopathy—Docetaxel—prostate cancer	9.59e-05	0.00062	CcSEcCtD
Bimatoprost—Eye disorder—Capecitabine—prostate cancer	9.56e-05	0.000618	CcSEcCtD
Bimatoprost—Dyspepsia—Mitoxantrone—prostate cancer	9.56e-05	0.000618	CcSEcCtD
Bimatoprost—Hypertension—Etoposide—prostate cancer	9.56e-05	0.000618	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—prostate cancer	9.53e-05	0.000617	CcSEcCtD
Bimatoprost—Mediastinal disorder—Docetaxel—prostate cancer	9.52e-05	0.000616	CcSEcCtD
Bimatoprost—Liver function test abnormal—Epirubicin—prostate cancer	9.51e-05	0.000615	CcSEcCtD
Bimatoprost—Dry skin—Epirubicin—prostate cancer	9.44e-05	0.000611	CcSEcCtD
Bimatoprost—Chest pain—Etoposide—prostate cancer	9.42e-05	0.000609	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	9.36e-05	0.000605	CcSEcCtD
Bimatoprost—Pain—Mitoxantrone—prostate cancer	9.29e-05	0.000601	CcSEcCtD
Bimatoprost—Angiopathy—Capecitabine—prostate cancer	9.28e-05	0.0006	CcSEcCtD
Bimatoprost—Rash—Goserelin—prostate cancer	9.27e-05	0.0006	CcSEcCtD
Bimatoprost—Dermatitis—Goserelin—prostate cancer	9.26e-05	0.000599	CcSEcCtD
Bimatoprost—Mediastinal disorder—Capecitabine—prostate cancer	9.22e-05	0.000596	CcSEcCtD
Bimatoprost—Nasopharyngitis—Epirubicin—prostate cancer	9.21e-05	0.000596	CcSEcCtD
Bimatoprost—Headache—Goserelin—prostate cancer	9.21e-05	0.000596	CcSEcCtD
Bimatoprost—Erythema—Docetaxel—prostate cancer	9.2e-05	0.000595	CcSEcCtD
Bimatoprost—Rash—Conjugated Estrogens—prostate cancer	9.18e-05	0.000594	CcSEcCtD
Bimatoprost—Dermatitis—Conjugated Estrogens—prostate cancer	9.17e-05	0.000593	CcSEcCtD
Bimatoprost—Headache—Conjugated Estrogens—prostate cancer	9.12e-05	0.00059	CcSEcCtD
Bimatoprost—Infection—Etoposide—prostate cancer	8.97e-05	0.00058	CcSEcCtD
Bimatoprost—Connective tissue disorder—Prednisone—prostate cancer	8.96e-05	0.000579	CcSEcCtD
Bimatoprost—Erythema—Capecitabine—prostate cancer	8.91e-05	0.000576	CcSEcCtD
Bimatoprost—Asthma—Epirubicin—prostate cancer	8.9e-05	0.000576	CcSEcCtD
Bimatoprost—Liver function test abnormal—Doxorubicin—prostate cancer	8.8e-05	0.000569	CcSEcCtD
Bimatoprost—Skin disorder—Etoposide—prostate cancer	8.77e-05	0.000567	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—prostate cancer	8.74e-05	0.000565	CcSEcCtD
Bimatoprost—Nausea—Goserelin—prostate cancer	8.73e-05	0.000565	CcSEcCtD
Bimatoprost—Nausea—Conjugated Estrogens—prostate cancer	8.65e-05	0.000559	CcSEcCtD
Bimatoprost—Bronchitis—Epirubicin—prostate cancer	8.56e-05	0.000554	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—prostate cancer	8.52e-05	0.000551	CcSEcCtD
Bimatoprost—Eye disorder—Prednisone—prostate cancer	8.52e-05	0.000551	CcSEcCtD
Bimatoprost—Vision blurred—Capecitabine—prostate cancer	8.39e-05	0.000543	CcSEcCtD
Bimatoprost—Asthenia—Estradiol—prostate cancer	8.36e-05	0.000541	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Epirubicin—prostate cancer	8.28e-05	0.000535	CcSEcCtD
Bimatoprost—Angiopathy—Prednisone—prostate cancer	8.27e-05	0.000535	CcSEcCtD
Bimatoprost—Pruritus—Estradiol—prostate cancer	8.25e-05	0.000533	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—prostate cancer	8.24e-05	0.000533	CcSEcCtD
Bimatoprost—Palpitations—Docetaxel—prostate cancer	8.13e-05	0.000526	CcSEcCtD
Bimatoprost—Dyspnoea—Etoposide—prostate cancer	8.05e-05	0.000521	CcSEcCtD
Bimatoprost—Somnolence—Etoposide—prostate cancer	8.03e-05	0.000519	CcSEcCtD
Bimatoprost—Cough—Docetaxel—prostate cancer	8.03e-05	0.000519	CcSEcCtD
Bimatoprost—Vertigo—Capecitabine—prostate cancer	8e-05	0.000517	CcSEcCtD
Bimatoprost—Hypertension—Docetaxel—prostate cancer	7.94e-05	0.000514	CcSEcCtD
Bimatoprost—Erythema—Prednisone—prostate cancer	7.93e-05	0.000513	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—prostate cancer	7.92e-05	0.000512	CcSEcCtD
Bimatoprost—Palpitations—Capecitabine—prostate cancer	7.87e-05	0.000509	CcSEcCtD
Bimatoprost—Chest pain—Docetaxel—prostate cancer	7.83e-05	0.000506	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Etoposide—prostate cancer	7.8e-05	0.000504	CcSEcCtD
Bimatoprost—Asthenia—Mitoxantrone—prostate cancer	7.79e-05	0.000504	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	7.78e-05	0.000503	CcSEcCtD
Bimatoprost—Cough—Capecitabine—prostate cancer	7.77e-05	0.000503	CcSEcCtD
Bimatoprost—Pain—Etoposide—prostate cancer	7.73e-05	0.0005	CcSEcCtD
Bimatoprost—Dizziness—Estradiol—prostate cancer	7.71e-05	0.000498	CcSEcCtD
Bimatoprost—Hypertension—Capecitabine—prostate cancer	7.69e-05	0.000497	CcSEcCtD
Bimatoprost—Dry mouth—Docetaxel—prostate cancer	7.66e-05	0.000495	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—prostate cancer	7.66e-05	0.000495	CcSEcCtD
Bimatoprost—Chest pain—Capecitabine—prostate cancer	7.58e-05	0.00049	CcSEcCtD
Bimatoprost—Anxiety—Capecitabine—prostate cancer	7.56e-05	0.000489	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.53e-05	0.000487	CcSEcCtD
Bimatoprost—Vision blurred—Prednisone—prostate cancer	7.48e-05	0.000484	CcSEcCtD
Bimatoprost—Infection—Docetaxel—prostate cancer	7.46e-05	0.000482	CcSEcCtD
Bimatoprost—Sinusitis—Epirubicin—prostate cancer	7.45e-05	0.000482	CcSEcCtD
Bimatoprost—Dry mouth—Capecitabine—prostate cancer	7.42e-05	0.00048	CcSEcCtD
Bimatoprost—Nervous system disorder—Docetaxel—prostate cancer	7.36e-05	0.000476	CcSEcCtD
Bimatoprost—Rash—Estradiol—prostate cancer	7.35e-05	0.000475	CcSEcCtD
Bimatoprost—Dermatitis—Estradiol—prostate cancer	7.34e-05	0.000475	CcSEcCtD
Bimatoprost—Headache—Estradiol—prostate cancer	7.3e-05	0.000472	CcSEcCtD
Bimatoprost—Skin disorder—Docetaxel—prostate cancer	7.29e-05	0.000472	CcSEcCtD
Bimatoprost—Infection—Capecitabine—prostate cancer	7.22e-05	0.000467	CcSEcCtD
Bimatoprost—Rhinitis—Epirubicin—prostate cancer	7.15e-05	0.000462	CcSEcCtD
Bimatoprost—Nervous system disorder—Capecitabine—prostate cancer	7.13e-05	0.000461	CcSEcCtD
Bimatoprost—Vertigo—Prednisone—prostate cancer	7.13e-05	0.000461	CcSEcCtD
Bimatoprost—Pharyngitis—Epirubicin—prostate cancer	7.07e-05	0.000457	CcSEcCtD
Bimatoprost—Skin disorder—Capecitabine—prostate cancer	7.06e-05	0.000457	CcSEcCtD
Bimatoprost—Oedema peripheral—Epirubicin—prostate cancer	7.02e-05	0.000454	CcSEcCtD
Bimatoprost—Connective tissue disorder—Epirubicin—prostate cancer	7e-05	0.000453	CcSEcCtD
Bimatoprost—Nausea—Estradiol—prostate cancer	6.92e-05	0.000448	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—prostate cancer	6.89e-05	0.000446	CcSEcCtD
Bimatoprost—Visual impairment—Epirubicin—prostate cancer	6.87e-05	0.000444	CcSEcCtD
Bimatoprost—Hypertension—Prednisone—prostate cancer	6.85e-05	0.000443	CcSEcCtD
Bimatoprost—Rash—Mitoxantrone—prostate cancer	6.85e-05	0.000443	CcSEcCtD
Bimatoprost—Dermatitis—Mitoxantrone—prostate cancer	6.84e-05	0.000442	CcSEcCtD
Bimatoprost—Headache—Mitoxantrone—prostate cancer	6.8e-05	0.00044	CcSEcCtD
Bimatoprost—Insomnia—Docetaxel—prostate cancer	6.79e-05	0.000439	CcSEcCtD
Bimatoprost—Anxiety—Prednisone—prostate cancer	6.73e-05	0.000435	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.71e-05	0.000434	CcSEcCtD
Bimatoprost—Dyspnoea—Docetaxel—prostate cancer	6.69e-05	0.000433	CcSEcCtD
Bimatoprost—Somnolence—Docetaxel—prostate cancer	6.67e-05	0.000432	CcSEcCtD
Bimatoprost—Eye disorder—Epirubicin—prostate cancer	6.66e-05	0.000431	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—prostate cancer	6.61e-05	0.000428	CcSEcCtD
Bimatoprost—Dyspepsia—Docetaxel—prostate cancer	6.61e-05	0.000427	CcSEcCtD
Bimatoprost—Insomnia—Capecitabine—prostate cancer	6.57e-05	0.000425	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—prostate cancer	6.55e-05	0.000423	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—prostate cancer	6.5e-05	0.00042	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Docetaxel—prostate cancer	6.48e-05	0.000419	CcSEcCtD
Bimatoprost—Asthenia—Etoposide—prostate cancer	6.48e-05	0.000419	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—prostate cancer	6.48e-05	0.000419	CcSEcCtD
Bimatoprost—Dyspnoea—Capecitabine—prostate cancer	6.48e-05	0.000419	CcSEcCtD
Bimatoprost—Angiopathy—Epirubicin—prostate cancer	6.47e-05	0.000418	CcSEcCtD
Bimatoprost—Nausea—Mitoxantrone—prostate cancer	6.45e-05	0.000417	CcSEcCtD
Bimatoprost—Infection—Prednisone—prostate cancer	6.43e-05	0.000416	CcSEcCtD
Bimatoprost—Mediastinal disorder—Epirubicin—prostate cancer	6.42e-05	0.000415	CcSEcCtD
Bimatoprost—Pain—Docetaxel—prostate cancer	6.42e-05	0.000415	CcSEcCtD
Bimatoprost—Dyspepsia—Capecitabine—prostate cancer	6.4e-05	0.000414	CcSEcCtD
Bimatoprost—Pruritus—Etoposide—prostate cancer	6.39e-05	0.000413	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—prostate cancer	6.36e-05	0.000411	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—prostate cancer	6.35e-05	0.000411	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—prostate cancer	6.29e-05	0.000407	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Capecitabine—prostate cancer	6.28e-05	0.000406	CcSEcCtD
Bimatoprost—Pain—Capecitabine—prostate cancer	6.22e-05	0.000402	CcSEcCtD
Bimatoprost—Erythema—Epirubicin—prostate cancer	6.2e-05	0.000401	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—prostate cancer	6.16e-05	0.000399	CcSEcCtD
Bimatoprost—Tension—Epirubicin—prostate cancer	6.09e-05	0.000394	CcSEcCtD
Bimatoprost—Nervousness—Epirubicin—prostate cancer	6.03e-05	0.00039	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—prostate cancer	5.98e-05	0.000387	CcSEcCtD
Bimatoprost—Dizziness—Etoposide—prostate cancer	5.97e-05	0.000386	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—prostate cancer	5.94e-05	0.000384	CcSEcCtD
Bimatoprost—Insomnia—Prednisone—prostate cancer	5.86e-05	0.000379	CcSEcCtD
Bimatoprost—Vision blurred—Epirubicin—prostate cancer	5.85e-05	0.000378	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—prostate cancer	5.74e-05	0.000371	CcSEcCtD
Bimatoprost—Dyspepsia—Prednisone—prostate cancer	5.7e-05	0.000369	CcSEcCtD
Bimatoprost—Rash—Etoposide—prostate cancer	5.7e-05	0.000368	CcSEcCtD
Bimatoprost—Dermatitis—Etoposide—prostate cancer	5.69e-05	0.000368	CcSEcCtD
Bimatoprost—Headache—Etoposide—prostate cancer	5.66e-05	0.000366	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—prostate cancer	5.63e-05	0.000364	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—prostate cancer	5.58e-05	0.000361	CcSEcCtD
Bimatoprost—Vertigo—Epirubicin—prostate cancer	5.57e-05	0.000361	CcSEcCtD
Bimatoprost—Palpitations—Epirubicin—prostate cancer	5.48e-05	0.000355	CcSEcCtD
Bimatoprost—Cough—Epirubicin—prostate cancer	5.41e-05	0.00035	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—prostate cancer	5.41e-05	0.00035	CcSEcCtD
Bimatoprost—Asthenia—Docetaxel—prostate cancer	5.39e-05	0.000348	CcSEcCtD
Bimatoprost—Nausea—Etoposide—prostate cancer	5.37e-05	0.000347	CcSEcCtD
Bimatoprost—Hypertension—Epirubicin—prostate cancer	5.36e-05	0.000346	CcSEcCtD
Bimatoprost—Pruritus—Docetaxel—prostate cancer	5.31e-05	0.000344	CcSEcCtD
Bimatoprost—Chest pain—Epirubicin—prostate cancer	5.28e-05	0.000342	CcSEcCtD
Bimatoprost—Anxiety—Epirubicin—prostate cancer	5.26e-05	0.00034	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.25e-05	0.000339	CcSEcCtD
Bimatoprost—Asthenia—Capecitabine—prostate cancer	5.22e-05	0.000337	CcSEcCtD
Bimatoprost—Dry mouth—Epirubicin—prostate cancer	5.17e-05	0.000334	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—prostate cancer	5.16e-05	0.000334	CcSEcCtD
Bimatoprost—Pruritus—Capecitabine—prostate cancer	5.14e-05	0.000333	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—prostate cancer	5.07e-05	0.000328	CcSEcCtD
Bimatoprost—Infection—Epirubicin—prostate cancer	5.03e-05	0.000325	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—prostate cancer	5.01e-05	0.000324	CcSEcCtD
Bimatoprost—Nervous system disorder—Epirubicin—prostate cancer	4.97e-05	0.000321	CcSEcCtD
Bimatoprost—Dizziness—Docetaxel—prostate cancer	4.96e-05	0.000321	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—prostate cancer	4.96e-05	0.000321	CcSEcCtD
Bimatoprost—Skin disorder—Epirubicin—prostate cancer	4.92e-05	0.000318	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—prostate cancer	4.89e-05	0.000316	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—prostate cancer	4.87e-05	0.000315	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.85e-05	0.000314	CcSEcCtD
Bimatoprost—Dizziness—Capecitabine—prostate cancer	4.81e-05	0.000311	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—prostate cancer	4.78e-05	0.000309	CcSEcCtD
Bimatoprost—Rash—Docetaxel—prostate cancer	4.73e-05	0.000306	CcSEcCtD
Bimatoprost—Dermatitis—Docetaxel—prostate cancer	4.73e-05	0.000306	CcSEcCtD
Bimatoprost—Headache—Docetaxel—prostate cancer	4.7e-05	0.000304	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—prostate cancer	4.65e-05	0.000301	CcSEcCtD
Bimatoprost—Asthenia—Prednisone—prostate cancer	4.65e-05	0.0003	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—prostate cancer	4.59e-05	0.000297	CcSEcCtD
Bimatoprost—Rash—Capecitabine—prostate cancer	4.58e-05	0.000296	CcSEcCtD
Bimatoprost—Pruritus—Prednisone—prostate cancer	4.58e-05	0.000296	CcSEcCtD
Bimatoprost—Insomnia—Epirubicin—prostate cancer	4.58e-05	0.000296	CcSEcCtD
Bimatoprost—Dermatitis—Capecitabine—prostate cancer	4.58e-05	0.000296	CcSEcCtD
Bimatoprost—Headache—Capecitabine—prostate cancer	4.55e-05	0.000294	CcSEcCtD
Bimatoprost—Skin disorder—Doxorubicin—prostate cancer	4.55e-05	0.000294	CcSEcCtD
Bimatoprost—Dyspnoea—Epirubicin—prostate cancer	4.51e-05	0.000292	CcSEcCtD
Bimatoprost—Somnolence—Epirubicin—prostate cancer	4.5e-05	0.000291	CcSEcCtD
Bimatoprost—Nausea—Docetaxel—prostate cancer	4.46e-05	0.000288	CcSEcCtD
Bimatoprost—Dyspepsia—Epirubicin—prostate cancer	4.46e-05	0.000288	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Epirubicin—prostate cancer	4.37e-05	0.000283	CcSEcCtD
Bimatoprost—Pain—Epirubicin—prostate cancer	4.33e-05	0.00028	CcSEcCtD
Bimatoprost—Nausea—Capecitabine—prostate cancer	4.32e-05	0.000279	CcSEcCtD
Bimatoprost—Dizziness—Prednisone—prostate cancer	4.28e-05	0.000277	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—prostate cancer	4.24e-05	0.000274	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—prostate cancer	4.18e-05	0.00027	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—prostate cancer	4.17e-05	0.000269	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—prostate cancer	4.12e-05	0.000267	CcSEcCtD
Bimatoprost—Rash—Prednisone—prostate cancer	4.08e-05	0.000264	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—prostate cancer	4.08e-05	0.000264	CcSEcCtD
Bimatoprost—Headache—Prednisone—prostate cancer	4.06e-05	0.000262	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.05e-05	0.000262	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—prostate cancer	4.01e-05	0.000259	CcSEcCtD
Bimatoprost—Nausea—Prednisone—prostate cancer	3.85e-05	0.000249	CcSEcCtD
Bimatoprost—Asthenia—Epirubicin—prostate cancer	3.63e-05	0.000235	CcSEcCtD
Bimatoprost—Pruritus—Epirubicin—prostate cancer	3.58e-05	0.000232	CcSEcCtD
Bimatoprost—Asthenia—Doxorubicin—prostate cancer	3.36e-05	0.000217	CcSEcCtD
Bimatoprost—Dizziness—Epirubicin—prostate cancer	3.35e-05	0.000217	CcSEcCtD
Bimatoprost—Pruritus—Doxorubicin—prostate cancer	3.31e-05	0.000214	CcSEcCtD
Bimatoprost—Rash—Epirubicin—prostate cancer	3.19e-05	0.000206	CcSEcCtD
Bimatoprost—Dermatitis—Epirubicin—prostate cancer	3.19e-05	0.000206	CcSEcCtD
Bimatoprost—Headache—Epirubicin—prostate cancer	3.17e-05	0.000205	CcSEcCtD
Bimatoprost—Dizziness—Doxorubicin—prostate cancer	3.1e-05	0.0002	CcSEcCtD
Bimatoprost—Nausea—Epirubicin—prostate cancer	3.01e-05	0.000195	CcSEcCtD
Bimatoprost—Rash—Doxorubicin—prostate cancer	2.95e-05	0.000191	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—prostate cancer	2.95e-05	0.000191	CcSEcCtD
Bimatoprost—Headache—Doxorubicin—prostate cancer	2.94e-05	0.00019	CcSEcCtD
Bimatoprost—Nausea—Doxorubicin—prostate cancer	2.78e-05	0.00018	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CB—prostate cancer	1.42e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—GSK3B—prostate cancer	1.41e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LPL—prostate cancer	1.41e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—prostate cancer	1.4e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GSK3B—prostate cancer	1.4e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDGFRB—prostate cancer	1.4e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ITGB3—prostate cancer	1.39e-05	0.000113	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—INS—prostate cancer	1.39e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CB—prostate cancer	1.39e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—INS—prostate cancer	1.38e-05	0.000112	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CREBBP—prostate cancer	1.36e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ITGB3—prostate cancer	1.36e-05	0.000111	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LPL—prostate cancer	1.36e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—prostate cancer	1.36e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAV1—prostate cancer	1.35e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CREBBP—prostate cancer	1.35e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB3—prostate cancer	1.35e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFRB—prostate cancer	1.35e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGFR2—prostate cancer	1.35e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—prostate cancer	1.34e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—prostate cancer	1.33e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—prostate cancer	1.33e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB3—prostate cancer	1.32e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGFR2—prostate cancer	1.32e-05	0.000107	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ITGB3—prostate cancer	1.32e-05	0.000107	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAP2K1—prostate cancer	1.3e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—prostate cancer	1.3e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TERT—prostate cancer	1.3e-05	0.000105	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—prostate cancer	1.29e-05	0.000105	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.29e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAP2K1—prostate cancer	1.29e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—prostate cancer	1.28e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—prostate cancer	1.28e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB3—prostate cancer	1.28e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGFR2—prostate cancer	1.27e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—prostate cancer	1.27e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—prostate cancer	1.27e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—prostate cancer	1.27e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TERT—prostate cancer	1.27e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—prostate cancer	1.26e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGF2—prostate cancer	1.24e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—prostate cancer	1.24e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—prostate cancer	1.23e-05	9.99e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGF2—prostate cancer	1.23e-05	9.96e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TERT—prostate cancer	1.22e-05	9.91e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—prostate cancer	1.22e-05	9.9e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—prostate cancer	1.21e-05	9.83e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—prostate cancer	1.21e-05	9.82e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—prostate cancer	1.21e-05	9.8e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CAV1—prostate cancer	1.2e-05	9.71e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—JAK2—prostate cancer	1.19e-05	9.62e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—prostate cancer	1.18e-05	9.6e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—prostate cancer	1.18e-05	9.59e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JAK2—prostate cancer	1.18e-05	9.54e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CAV1—prostate cancer	1.17e-05	9.5e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—prostate cancer	1.17e-05	9.48e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—INS—prostate cancer	1.17e-05	9.46e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—prostate cancer	1.16e-05	9.4e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MDM2—prostate cancer	1.16e-05	9.39e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ESR1—prostate cancer	1.15e-05	9.36e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—prostate cancer	1.15e-05	9.35e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MDM2—prostate cancer	1.15e-05	9.32e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CREBBP—prostate cancer	1.14e-05	9.26e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—prostate cancer	1.14e-05	9.26e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—prostate cancer	1.14e-05	9.26e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—prostate cancer	1.13e-05	9.18e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CAV1—prostate cancer	1.13e-05	9.17e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ESR1—prostate cancer	1.13e-05	9.16e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—prostate cancer	1.13e-05	9.14e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BAD—prostate cancer	1.13e-05	9.13e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—prostate cancer	1.12e-05	9.07e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—prostate cancer	1.12e-05	9.06e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—prostate cancer	1.12e-05	9.06e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BAD—prostate cancer	1.1e-05	8.94e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—prostate cancer	1.09e-05	8.85e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—prostate cancer	1.09e-05	8.85e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ESR1—prostate cancer	1.09e-05	8.84e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—prostate cancer	1.08e-05	8.78e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGF—prostate cancer	1.08e-05	8.74e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS1—prostate cancer	1.08e-05	8.74e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—prostate cancer	1.07e-05	8.71e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—prostate cancer	1.07e-05	8.66e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—prostate cancer	1.07e-05	8.66e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BAD—prostate cancer	1.06e-05	8.62e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1B—prostate cancer	1.06e-05	8.58e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGF—prostate cancer	1.06e-05	8.56e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS1—prostate cancer	1.06e-05	8.56e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1B—prostate cancer	1.05e-05	8.51e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GSK3B—prostate cancer	1.05e-05	8.49e-05	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—prostate cancer	1.04e-05	8.41e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INS—prostate cancer	1.03e-05	8.37e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—prostate cancer	1.03e-05	8.35e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—prostate cancer	1.03e-05	8.35e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—prostate cancer	1.03e-05	8.34e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—prostate cancer	1.03e-05	8.32e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GSK3B—prostate cancer	1.03e-05	8.31e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—prostate cancer	1.02e-05	8.29e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—prostate cancer	1.02e-05	8.28e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGF—prostate cancer	1.02e-05	8.26e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS1—prostate cancer	1.02e-05	8.26e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CREBBP—prostate cancer	1.01e-05	8.2e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INS—prostate cancer	1.01e-05	8.2e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—prostate cancer	1e-05	8.11e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CTNNB1—prostate cancer	1e-05	8.1e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—prostate cancer	9.99e-06	8.1e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—prostate cancer	9.94e-06	8.06e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNB1—prostate cancer	9.92e-06	8.04e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CREBBP—prostate cancer	9.91e-06	8.03e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GSK3B—prostate cancer	9.89e-06	8.02e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—prostate cancer	9.78e-06	7.93e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1A—prostate cancer	9.77e-06	7.92e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INS—prostate cancer	9.76e-06	7.91e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—prostate cancer	9.75e-06	7.9e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—prostate cancer	9.73e-06	7.89e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—prostate cancer	9.72e-06	7.88e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1A—prostate cancer	9.69e-06	7.85e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—prostate cancer	9.66e-06	7.83e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAP2K1—prostate cancer	9.66e-06	7.83e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—prostate cancer	9.6e-06	7.78e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CREBBP—prostate cancer	9.56e-06	7.74e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—prostate cancer	9.5e-06	7.7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—prostate cancer	9.49e-06	7.69e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAP2K1—prostate cancer	9.45e-06	7.66e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—prostate cancer	9.45e-06	7.65e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—prostate cancer	9.44e-06	7.65e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—prostate cancer	9.43e-06	7.64e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—prostate cancer	9.39e-06	7.61e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—prostate cancer	9.39e-06	7.61e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—prostate cancer	9.36e-06	7.58e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—prostate cancer	9.3e-06	7.54e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EP300—prostate cancer	9.29e-06	7.53e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—prostate cancer	9.29e-06	7.53e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EP300—prostate cancer	9.22e-06	7.47e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—prostate cancer	9.2e-06	7.45e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGF2—prostate cancer	9.19e-06	7.45e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAP2K1—prostate cancer	9.12e-06	7.39e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—prostate cancer	9.06e-06	7.34e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—prostate cancer	9.06e-06	7.34e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SRC—prostate cancer	9.04e-06	7.32e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGF2—prostate cancer	8.99e-06	7.29e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SRC—prostate cancer	8.96e-06	7.26e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—prostate cancer	8.96e-06	7.26e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—prostate cancer	8.87e-06	7.19e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JAK2—prostate cancer	8.81e-06	7.14e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—prostate cancer	8.73e-06	7.07e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—prostate cancer	8.72e-06	7.06e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGF2—prostate cancer	8.68e-06	7.03e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—prostate cancer	8.64e-06	7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—prostate cancer	8.63e-06	6.99e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JAK2—prostate cancer	8.62e-06	6.99e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MDM2—prostate cancer	8.6e-06	6.97e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—prostate cancer	8.56e-06	6.93e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—prostate cancer	8.48e-06	6.87e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—prostate cancer	8.45e-06	6.85e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MDM2—prostate cancer	8.41e-06	6.82e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—prostate cancer	8.36e-06	6.78e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JAK2—prostate cancer	8.32e-06	6.74e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—prostate cancer	8.3e-06	6.72e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—prostate cancer	8.19e-06	6.63e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—prostate cancer	8.16e-06	6.61e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MDM2—prostate cancer	8.12e-06	6.58e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—prostate cancer	8.1e-06	6.56e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—prostate cancer	8.08e-06	6.55e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—prostate cancer	8.04e-06	6.51e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—prostate cancer	8.03e-06	6.51e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—prostate cancer	8.01e-06	6.49e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—prostate cancer	8e-06	6.49e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—prostate cancer	7.92e-06	6.42e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—prostate cancer	7.9e-06	6.4e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—prostate cancer	7.87e-06	6.38e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—prostate cancer	7.86e-06	6.37e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1B—prostate cancer	7.85e-06	6.36e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—EP300—prostate cancer	7.78e-06	6.31e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—prostate cancer	7.76e-06	6.29e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—prostate cancer	7.69e-06	6.23e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1B—prostate cancer	7.68e-06	6.23e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—prostate cancer	7.68e-06	6.22e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—prostate cancer	7.64e-06	6.19e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—prostate cancer	7.6e-06	6.16e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—prostate cancer	7.59e-06	6.15e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—prostate cancer	7.53e-06	6.1e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—prostate cancer	7.52e-06	6.09e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—prostate cancer	7.49e-06	6.07e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—prostate cancer	7.48e-06	6.06e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—prostate cancer	7.48e-06	6.06e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—prostate cancer	7.42e-06	6.01e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CTNNB1—prostate cancer	7.42e-06	6.01e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1B—prostate cancer	7.41e-06	6.01e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—prostate cancer	7.33e-06	5.94e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—prostate cancer	7.27e-06	5.89e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—prostate cancer	7.26e-06	5.89e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CTNNB1—prostate cancer	7.26e-06	5.88e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—prostate cancer	7.25e-06	5.88e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1A—prostate cancer	7.24e-06	5.87e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—prostate cancer	7.23e-06	5.86e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—prostate cancer	7.12e-06	5.77e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1A—prostate cancer	7.09e-06	5.75e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—prostate cancer	7.07e-06	5.73e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—prostate cancer	7.07e-06	5.73e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—prostate cancer	7.05e-06	5.71e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNB1—prostate cancer	7e-06	5.67e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—prostate cancer	6.9e-06	5.59e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EP300—prostate cancer	6.89e-06	5.59e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—prostate cancer	6.88e-06	5.57e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—prostate cancer	6.87e-06	5.56e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1A—prostate cancer	6.84e-06	5.54e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—prostate cancer	6.83e-06	5.53e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—prostate cancer	6.82e-06	5.53e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EP300—prostate cancer	6.75e-06	5.47e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SRC—prostate cancer	6.7e-06	5.43e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—prostate cancer	6.6e-06	5.35e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SRC—prostate cancer	6.56e-06	5.32e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—prostate cancer	6.53e-06	5.29e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EP300—prostate cancer	6.51e-06	5.27e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—prostate cancer	6.46e-06	5.24e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—prostate cancer	6.39e-06	5.18e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SRC—prostate cancer	6.33e-06	5.13e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—prostate cancer	6.33e-06	5.13e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—prostate cancer	6.16e-06	5e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—prostate cancer	6.1e-06	4.95e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—prostate cancer	6.09e-06	4.93e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—prostate cancer	6.04e-06	4.89e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—prostate cancer	6.01e-06	4.87e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—prostate cancer	5.99e-06	4.86e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—prostate cancer	5.88e-06	4.76e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—prostate cancer	5.87e-06	4.76e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—prostate cancer	5.86e-06	4.75e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—prostate cancer	5.76e-06	4.67e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—prostate cancer	5.75e-06	4.66e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—prostate cancer	5.67e-06	4.6e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—prostate cancer	5.66e-06	4.59e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—prostate cancer	5.62e-06	4.55e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—prostate cancer	5.57e-06	4.51e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—prostate cancer	5.55e-06	4.5e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—prostate cancer	5.55e-06	4.5e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—prostate cancer	5.43e-06	4.4e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—prostate cancer	5.24e-06	4.25e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—prostate cancer	5.1e-06	4.13e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—prostate cancer	4.99e-06	4.04e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—prostate cancer	4.93e-06	4e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—prostate cancer	4.83e-06	3.91e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—prostate cancer	4.81e-06	3.9e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—prostate cancer	4.7e-06	3.81e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—prostate cancer	4.66e-06	3.77e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—prostate cancer	4.51e-06	3.66e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—prostate cancer	4.42e-06	3.58e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—prostate cancer	4.26e-06	3.46e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—prostate cancer	4.17e-06	3.38e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—prostate cancer	4.08e-06	3.3e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—prostate cancer	3.93e-06	3.19e-05	CbGpPWpGaD
